1078 related articles for article (PubMed ID: 27241020)
1. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
[TBL] [Abstract][Full Text] [Related]
2. The water extract of Liuwei dihuang possesses multi-protective properties on neurons and muscle tissue against deficiency of survival motor neuron protein.
Tseng YT; Jong YJ; Liang WF; Chang FR; Lo YC
Phytomedicine; 2017 Oct; 34():97-105. PubMed ID: 28899515
[TBL] [Abstract][Full Text] [Related]
3. Triptolide increases transcript and protein levels of survival motor neurons in human SMA fibroblasts and improves survival in SMA-like mice.
Hsu YY; Jong YJ; Tsai HH; Tseng YT; An LM; Lo YC
Br J Pharmacol; 2012 Jun; 166(3):1114-26. PubMed ID: 22220673
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
[TBL] [Abstract][Full Text] [Related]
5. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
[TBL] [Abstract][Full Text] [Related]
6. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
[TBL] [Abstract][Full Text] [Related]
7. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.
Morales MG; Abrigo J; Acuña MJ; Santos RA; Bader M; Brandan E; Simon F; Olguin H; Cabrera D; Cabello-Verrugio C
Dis Model Mech; 2016 Apr; 9(4):441-9. PubMed ID: 26851244
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy.
Lumpkin CJ; Harris AW; Connell AJ; Kirk RW; Whiting JA; Saieva L; Pellizzoni L; Burghes AHM; Butchbach MER
Sci Rep; 2023 Jun; 13(1):10374. PubMed ID: 37365234
[TBL] [Abstract][Full Text] [Related]
10. The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy.
Liu H; Yazdani A; Murray LM; Beauvais A; Kothary R
PLoS One; 2014; 9(7):e101225. PubMed ID: 24984019
[TBL] [Abstract][Full Text] [Related]
11. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice.
de la Fuente S; Sansa A; Periyakaruppiah A; Garcera A; Soler RM
Mol Neurobiol; 2019 Jun; 56(6):4414-4427. PubMed ID: 30327977
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of exercise-induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy-like mice.
Ng SY; Mikhail A; Ljubicic V
J Physiol; 2019 Sep; 597(18):4757-4778. PubMed ID: 31361024
[TBL] [Abstract][Full Text] [Related]
13. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
Kannan A; Jiang X; He L; Ahmad S; Gangwani L
Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288
[TBL] [Abstract][Full Text] [Related]
14. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
[TBL] [Abstract][Full Text] [Related]
15. Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy.
Iyer CC; McGovern VL; Wise DO; Glass DJ; Burghes AH
Neuromuscul Disord; 2014 May; 24(5):436-44. PubMed ID: 24656734
[TBL] [Abstract][Full Text] [Related]
16. Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy.
Bowerman M; Murray LM; Boyer JG; Anderson CL; Kothary R
BMC Med; 2012 Mar; 10():24. PubMed ID: 22397316
[TBL] [Abstract][Full Text] [Related]
17. Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.
Rindt H; Buckley DM; Vale SM; Krogman M; Rose FF; Garcia ML; Lorson CL
Neuromuscul Disord; 2012 Mar; 22(3):277-85. PubMed ID: 22079083
[TBL] [Abstract][Full Text] [Related]
18. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
[TBL] [Abstract][Full Text] [Related]
19. Therapeutics development for spinal muscular atrophy.
Sumner CJ
NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
[TBL] [Abstract][Full Text] [Related]
20. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.
Tsai LK; Tsai MS; Ting CH; Li H
J Mol Med (Berl); 2008 Nov; 86(11):1243-54. PubMed ID: 18649067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]